BROW MEDICAL CENTRE
THE BROW, BURGESS HILL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 10 | 80.0% | |
| HF 4 | 2011 | 9 | 13 | 69.2% | |
| HF 4 | 2012 | 11 | 15 | 73.3% | |
| HF 4 | 2013 | 13 | 15 | 86.7% | |
| HF004 | 2014 | 1 | 1 | 100.0% | |
| HF004 | 2015 | 2 | 2 | 100.0% | |
| HF004 | 2016 | 3 | 4 | 75.0% | |
| HF004 | 2017 | 4 | 5 | 80.0% | |
| HF004 | 2018 | 8 | 8 | 100.0% | |
| HF004 | 2019 | 9 | 9 | 100.0% | |
| HF004 | 2020 | 23 | 33 | 69.7% | |
| HF006 | 2021 | 34 | 35 | 97.1% | |
| HF006 | 2022 | 42 | 43 | 97.7% | |
| HF006 | 2023 | 43 | 43 | 100.0% |
